PRO DEX INC|4Jan 28, 7:05 PM ET

Charlton Alisha 4

4 · PRO DEX INC · Filed Jan 28, 2021

Form 4

Period: 2020-12-07

Chief Financial Officer

Transactions

Award
Stock Option (Right-to-buy)
2020-12-07+4,250→ 4,250 total
Exercise: $39.00From: 2022-07-01Exp: 2032-07-01→ Common Stock (4,250 underlying)
Award
Stock Option (Right-to-buy)
2020-12-07+4,250→ 8,500 total
Exercise: $42.00From: 2024-07-01Exp: 2034-07-01→ Common Stock (4,250 underlying)
Award
Stock Option (Right-to-buy)
2020-12-07+4,250→ 21,250 total
Exercise: $50.00From: 2030-07-01Exp: 2040-07-01→ Common Stock (4,250 underlying)
Award
Stock Option (Right-to-buy)
2020-12-07+4,250→ 12,750 total
Exercise: $45.00From: 2026-07-01Exp: 2036-07-01→ Common Stock (4,250 underlying)
Award
Stock Option (Right-to-buy)
2020-12-07+4,250→ 17,000 total
Exercise: $47.50From: 2028-07-01Exp: 2038-07-01→ Common Stock (4,250 underlying)

Footnotes (1)

[F1]These options were awarded under Pro-Dex's 2016 Equity Incentive Plan. The percentage of options that may vest and become exercisable, if any, are 100%, 50%, and 25%, respectively, based upon the volume-weighted average price of Pro-Dex's common stock equaling or exceeding the applicable exercise price for the 60 trading days immediately preceding the date the option becomes exercisable, six months from the date the option becomes exercisable, or twelve months from the date the option becomes exercisable, respectively. Explanation of Responses:

Documents

1 file